Aim Immunotech Inc.

This study tests an experimental drug called Ampligen (rintatolimod) in people with severe chronic fatigue syndrome (CFS). Participants receive twice-weekly IV infusions over several months. The goal is to see if the drug can ease symptoms and improve quality of life for those wh…

This phase 2 trial tests whether adding the experimental drug Ampligen to standard care can help people with locally advanced pancreatic cancer that hasn't spread. About 90 participants who have completed at least four months of initial chemotherapy will receive either Ampligen p…